The World Health Organization (WHO) has recently approved the inclusion of the VIASURE Monkeypox Virus Real Time PCR Detection Kit in the list of in vitro diagnostic devices authorized for use in public health emergency situations (EUL).
Inclusion in this list acknowledges the quality, safety, and performance of our VIASURE Monkeypox Virus Real Time PCR Detection Kit, enabling its acquisition by international organizations and laboratories that are part of the WHO’s global surveillance network.
This product has been developed and marketed by Certest since 2022 through its specialized Molecular Biology unit. It offers fast, specific, and reliable diagnostics—capable of distinguishing monkeypox from other similar diseases, facilitating rapid patient diagnosis and epidemiological control.
Moreover, it’s worth noting that our kit includes lyophilized reagents, allowing it to be stored at room temperature. This is a significant advantage, especially considering that countries with the highest incidence of this virus often lack optimal storage conditions.
